CDC to launch bridge program for COVID-19 vaccines

The program would let uninsured and underinsured adults get vaccinated.

ATLANTA – The Centers for Disease Control and Prevention (CDC) will launch a program this fall to ensure COVID-19 vaccine access for underinsured adults.

In a press release, the CDC said there are an estimated 25-30 million adults without insurance in the U.S. plus more whose health insurance doesn’t cover vaccines after they transition to the commercial market.

“Protecting people from COVID-19 remains a top priority for CDC,” CDC Director Dr. Mandy Cohen said. “CDC is partnering with state and local public health agencies, health centers, and pharmacies to ensure that all adults nationwide maintain access to lifesaving COVID-19 vaccines. Ultimately, we know that vaccines save money and lives. Vaccination is especially important as we head into fall and winter, a time when COVID-19 and other respiratory diseases are likely to circulate.”

In the program, the CDC will purchase COVID-19 vaccines then distribute them, along with funding, to a network of state and local immunization programs. The agency said it will also work with national pharmacy chains and vaccine manufacturers to make sure uninsured people can access vaccines at retail pharmacy locations.

The CDC said in the statement that the bridge program is temporary and scheduled to end in December 2024. A longer term solution would be the Vaccines for Adults program that has not been voted into law yet.

For more information, go to the Bridge Access Program website.

Know a useful resource?

Share it with your community!

We aggregate links that connect to resources across Illinois. If you know of a site that should be included or want your website listed, please submit it!


Get LGBTQ news sent right to you!

We share original stories, plus essential headlines from across the state and beyond, to keep you current on LGBTQ issues and community.


This site uses cookies to provide you with a great user experience. By continuing to use this website, you consent to the use of cookies in accordance with our privacy policy.

Scroll to Top